We are live on ! Find out more
IH icon

iHuman
IH

7 hedge funds and large institutions have $7.29M invested in iHuman in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.15% less ownership

Funds ownership: 6.37% → 6.22% (-0.15%)

97% less capital inflows, than outflows

Capital inflows: $5.9K | Capital outflows: $195K

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$2.18K
2
State Street
State Street
Massachusetts
+$2.16K
3
UBS Group
UBS Group
Switzerland
+$1.55K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$194K
2
Bank of America
Bank of America
North Carolina
-$1.15K

IH Hedge Fund Activity: Q3 2022 in Review

7 of the 5,833 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q3 2022, worth a combined $7.29M — down 9.2% from $8.02M a quarter earlier.

Fund positioning in IH was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $2.18K. The largest seller was Morgan Stanley, cutting an estimated $194K.

  • 7 institutional investors held iHuman (IH) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $7.29M of iHuman stock for Q3 2022, down 9.2% quarter-over-quarter.
  • 1 fund opened new iHuman positions in Q3 2022 and 1 closed out, a net change of 0 holders.
  • The largest iHuman buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $2.18K added.
  • The largest iHuman seller in Q3 2022 was Morgan Stanley, an estimated $194K sold.

Based on aggregated 13F filings for Q3 2022.